Liposomal doxorubicin targeting mitochondria: A novel formulation to enhance anti-tumor effects of Doxil® in vitro and in vivo
Saeed Mohammadian Haftcheshmeh, Mahmoud Reza Jaafari, Mohammad Mashreghi, Amin Mehrabian, Seyedeh Hoda Alavizadeh, Parvin Zamani, Javad Zarqi, Mohammad Hasan Darvishi, Fatemeh Gheybi
Topics & Concepts
In vivoIn vitroPharmacologyDoxorubicinPeptideLiposomeCytotoxicityChemistryMedicineCancer researchBiochemistryBiologyChemotherapyInternal medicineBiotechnologyNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryAdvanced biosensing and bioanalysis techniques